Literature DB >> 19262527

Predictors of clinical outcomes following fundoplication for gastroesophageal reflux disease remain insufficiently defined: a systematic review.

Stanley Ip1, Athina Tatsioni, Alene Conant, Raffi Karagozian, Linda Fu, Priscilla Chew, Gowri Raman, Joseph Lau, Peter Bonis.   

Abstract

OBJECTIVES: Surgical treatment is a therapeutic option for patients with gastroesophageal reflux disease (GERD). It is unclear which patient characteristics influence postoperative success. The purpose of this paper was to review the literature on prognostic factors for patients with GERD treated with fundoplication.
METHODS: We searched Medline and the Cochrane Library Central for studies from 1966 through July 2007. We identified additional studies by reviewing bibliographies of retrieved articles and by consulting experts. We included English language studies that evaluated factors potentially affecting the outcomes after surgical treatments in patients with GERD. We recorded baseline patient characteristics associated with treatment efficacy, details on the study design, comparators, and definitions of outcomes.
RESULTS: We assessed 6,318 abstracts; 53 cohorts and 10 case-control studies met our inclusion criteria. Age, body mass index, sex, esophagitis grade, and dysmotility were generally not associated with treatment outcomes. There were no consistent associations between preoperative response to acid suppression medications, baseline symptoms, baseline acid exposure, degree of lower esophageal sphincter competence, or position of reflux and surgical outcomes. Certain psychological factors might be associated with worse treatment outcomes.
CONCLUSIONS: Although several preoperative predictors of surgical outcomes have been described, the quality and consistency of the data were mixed and the strength of the associations remains unclear. Additional studies with improved methodological designs are needed to better define which patient characteristics are associated with surgical outcomes following fundoplication.

Entities:  

Mesh:

Year:  2009        PMID: 19262527     DOI: 10.1038/ajg.2008.123

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

Review 1.  Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis.

Authors:  Nadja Rickenbacher; Thomas Kötter; Michael M Kochen; Martin Scherer; Eva Blozik
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

2.  New Approaches to Gastroesophageal Reflux Disease.

Authors:  William Kethman; Mary Hawn
Journal:  J Gastrointest Surg       Date:  2017-06-16       Impact factor: 3.452

3.  Transoral incisionless fundoplication is cost-effective for treatment of gastroesophageal reflux disease.

Authors:  Thomas R McCarty; Pichamol Jirapinyo; Lyndon P James; Sanchit Gupta; Walter W Chan; Christopher C Thompson
Journal:  Endosc Int Open       Date:  2022-07-15

4.  Esophagogastric junction distensibility is greater following Toupet compared to Nissen fundoplication.

Authors:  Reece K DeHaan; Daniel Davila; Matthew J Frelich; Jon C Gould
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584

5.  Factors affecting the treatment outcomes of laparoscopic fundoplication for erosive reflux esophagitis: findings of esophageal pathological function tests.

Authors:  Kazuto Tsuboi; Fumiaki Yano; Nobuo Omura; Masato Hoshino; Se-Ryung Yamamoto; Shunsuke Akimoto; Takahiro Masuda; Yuki Sakashita; Toru Ikegami
Journal:  Surg Today       Date:  2021-01-25       Impact factor: 2.549

Review 6.  Clinical applications of esophageal impedance monitoring and high-resolution manometry.

Authors:  Boudewijn F Kessing; André J P M Smout; Albert J Bredenoord
Journal:  Curr Gastroenterol Rep       Date:  2012-06

7.  Factors predicting outcomes of laparoscopic Nissen fundoplication for gastroesophageal reflux disease: experience at a single institution in Korea.

Authors:  Joong-Min Park; Beom Jin Kim; Jae Gyu Kim; Kyong-Choun Chi
Journal:  Ann Surg Treat Res       Date:  2017-03-24       Impact factor: 1.859

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.